G-CSFR mutations and defective G-CSFR signaling have been implicated in several clinical diseases related to disabled granulopoiesis, such as neutropenia—particularly severe congenital neutropenia and chemotherapy-induced febrile neutropenia [29, 30]. Here, CSF3R is linked to severe congenital neutropenia.